Shree Ganesh Remedies Shows Promising Growth in Recent Financial Results
Shree Ganesh Remedies, a microcap pharmaceutical company, reported a flat performance in the second quarter of fiscal year 2024-2025. However, the company's Profit After Tax (PAT) for the nine-month period has seen a 33.00% year on year growth, reaching Rs 23.66 crore. This indicates a positive trend in the near term for the company's financials.
Shree Ganesh Remedies, a microcap pharmaceutical company, recently announced its financial results for the quarter ending September 2024. The company's stock has been given a 'Sell' call by MarketsMOJO.According to the financial report, Shree Ganesh Remedies has shown a flat performance in the second quarter of the fiscal year 2024-2025. The company's score has remained the same in the last three months.
Despite this, there are some positive aspects to the company's financials. The Profit After Tax (PAT) for the nine-month period has seen a growth of 33.00% year on year, reaching Rs 23.66 crore. This indicates a positive trend in the near term for the company's PAT.
Moreover, the PAT for the nine-month period is higher at Rs 23.66 crore compared to the preceding 12-month period ending in September 2024, which was Rs 22.22 crore. This shows that the company has already surpassed its sales from the previous 12 months in just nine months.
Overall, while Shree Ganesh Remedies may have had a flat performance in the second quarter, its financials show promising growth in the near term. Investors should keep an eye on the company's future performance to make informed decisions.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
